DISPERMOX SUMMARY
DisperMox ® (amoxicillin tablets for oral suspension) Rx only
DisperMox contains amoxicillin, a semisynthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many gram-positive and gram-negative microorganisms.
Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY ß-lactamase-negative) strains of the designated microorganisms in the conditions listed below:
Infections of the ear, nose, and throat - due to Streptococcus spp. (α- and β-hemolytic strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae
Infections of the genitourinary tract - due to E. coli, P. mirabilis, or E. faecalis
Infections of the skin and skin structure - due to Streptococcus spp. (α- and β-hemolytic strains only), Staphylococcus spp., or E. coli
Infections of the lower respiratory tract -due to Streptococcus spp. (α- and β-hemolytic strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae
Gonorrhea, acute uncomplicated (ano-genital and urethral infections) - due to N. gonorrhoeae (males and females).
H. pylori eradication to reduce the risk of duodenal ulcer recurrence
Triple Therapy:
Amoxicillin/clarithromycin/lansoprazole
Amoxicillin, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. (See CLINICAL STUDIES and DOSAGE AND ADMINISTRATION.)
Dual Therapy:
Amoxicillin/lansoprazole
Amoxicillin, in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. (See the clarithromycin package insert, MICROBIOLOGY.) Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. (See CLINICAL STUDIES and DOSAGE AND ADMINISTRATION.)
|
|
NEWS HIGHLIGHTS
Published Studies Related to Dispermox (Amoxicillin)
Response of feline eosinophilic plaques and lip ulcers to amoxicillin
trihydrate-clavulanate potassium therapy: a randomized, double-blind
placebo-controlled prospective study. [2012] In this study, we evaluated the treatment of feline eosinophilic plaques and lip
ulcers with amoxicillin trihydrate-potassium clavulanate (Clavamox(®); Pfizer
Animal Health). Nineteen cats with clinical and cytological findings consistent
with eosinophilic plaques and/or lip ulcers were enrolled...
Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. [2011.09] AIM: To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ+amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP)... CONCLUSION: The adjunctive use of MTZ+AMX offers short-term clinical and microbiological benefits, over SRP alone, in the treatment of non-smokers subjects with generalized ChP. The added benefits of MTZ were less evident. (c) 2011 John Wiley & Sons A/S.
Efficacy of amoxicillin treatment in preventing postoperative complications in patients undergoing third molar surgery: a prospective, randomized, double-blind controlled study. [2011.06] PURPOSE: The aim of the present study was to evaluate and compare the occurrence of postoperative complications in patients receiving either pre- or postoperative amoxicillin versus placebo after third molar surgery... CONCLUSION: Amoxicillin administered pre- or postoperatively demonstrated greater efficacy than placebo in preventing postoperative complications in patients undergoing third molar surgery. The best results were obtained using the postoperative protocol. Copyright (c) 2011 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Treatment of streptococcal pharyngitis with once-daily amoxicillin versus intramuscular benzathine penicillin G in low-resource settings: a randomized controlled trial. [2011.06] BACKGROUND: Primary prevention of acute rheumatic fever is achieved by proper antibiotic treatment of group A beta -hemolytic streptococcal (GAS) pharyngitis... CONCLUSION: If compliance is a major issue, a single dose of IM BPG may be preferable for treatment of GAS pharyngitis.
Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. [2011.05.07] BACKGROUND: Researchers have suggested that antibiotics could cure acute appendicitis. We assessed the efficacy of amoxicillin plus clavulanic acid by comparison with emergency appendicectomy for treatment of patients with uncomplicated acute appendicitis... INTERPRETATION: Amoxicillin plus clavulanic acid was not non-inferior to emergency appendicectomy for treatment of acute appendicitis. Identification of predictive markers on CT scans might enable improved targeting of antibiotic treatment. FUNDING: French Ministry of Health, Programme Hospitalier de Recherche Clinique 2002. Copyright (c) 2011 Elsevier Ltd. All rights reserved.
Clinical Trials Related to Dispermox (Amoxicillin)
A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection [Recruiting]
The proposed study will test the hypothesis that H. pylori can be eradicated successfully
(>85%) using half-or full-dose "concomitant" non-bismuth quadruple therapy regimen:
rabeprazole, amoxicillin, clarithromycin and metronidazole twice daily for 7 days in
patients with peptic ulcers and H. pylori related gastritis.
Two hundred patients from the outpatient department and the endoscopy unit at AUBMC will be
enrolled in this open-label trial. Patients with positive CLO tests or urea breath tests,
documenting H. pylori infection, will be randomized into one of two groups: Full dose or half
dose the concomitant regimen, with 100 patients in each group. Compliance and side effects
will be assessed, and a urea breath test will be done for all patients after 4 weeks of
therapy completion to evaluate eradication rates. Success of therapy will be evaluated
according to intent-to treat and per-protocol analyses.
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children [Recruiting]
The goal of this study is to determine whether amoxicillin (AMX) alone has an appreciable
effect on upper gastrointestinal motility compared to placebo. In particular, induction of
phase III of the interdigestive migrating motor complex (MMC) by AMX will be the primary
outcome of the study. MMCs are periodic waves of electrical activity resulting in muscular
contractions that pass through the walls of the stomach and intestinal tract during the
fasting state. It is characterized by an initial period where there is a minimal electrical
activity and muscular contraction (phase I), followed by a gradual increase in the frequency
of contractions (phase III) that often leads to a characteristic cluster of contractions
(phase III). This cycle occurs only in the fasting state in normal individuals and the
frequency of phase III is quite varied, dependent on age and the presence of any underlying
abnormalities in gastrointestinal motility. Secondary outcomes will include characteristics
of the MMC, patient demographics in responders and non-responders, and the safety profile of
AMX at the intervention dose.
Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications [Completed]
To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin
oral antibiotic suspension medications in pediatric subjects. It was designed to determine if
Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications [Completed]
To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin
oral antibiotic suspension medications in pediatric subjects. It is designed to determine if
Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
Short Course of Amoxicillin for Erysipelas [Not yet recruiting]
The propose of this study is to determine whether a 6-day duration of oral amoxicillin
treatment of erysipelas is non-inferior to a 14-day standard duration intravenous then oral
amoxicillin regimen. This trial will be open but evaluation will be perform by a blind
evaluator.
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 10 ratings/reviews, Dispermox has an overall score of 5.60. The effectiveness score is 6.60 and the side effect score is 7. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
| | Dispermox review by 53 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Highly Effective |
| Side effects: | | No Side Effects | | | Treatment Info |
| Condition / reason: | | Tooth abscess |
| Dosage & duration: | | 1 tablet taken 4 times a day for the period of 7 days |
| Other conditions: | | none |
| Other drugs taken: | | none | | | Reported Results |
| Benefits: | | The abscess cleared totally after taking the stated dose for 4 days. The full 7 day course was however taken. |
| Side effects: | | There were no noticeable side effects. |
| Comments: | | The doctor advised taking 2 tablets for the first dose to 'kick start' it into my system, which I did. After 4 days of the treatment, the swelling and the pain had almost gone. I was then able to attend a dentist who could examine and treat the tooth that caused the abscess. |
|
| | Dispermox review by 20 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Considerably Effective |
| Side effects: | | Moderate Side Effects | | | Treatment Info |
| Condition / reason: | | Tonsillitis/Strep Throat |
| Dosage & duration: | | 500mg taken t.i.d. for the period of 10 days |
| Other conditions: | | none |
| Other drugs taken: | | oral contraceptive | | | Reported Results |
| Benefits: | | Cured the tonsilitis/strep throat |
| Side effects: | | Vaginal Yeast Infection, itchy red rash over entire body except face. Arms and legs had the most severe rash. |
| Comments: | | Instructed to take two 250mg capsules every 8 hrs for 10 days. No discussion about possible side effects or what to do should they occur. I thought my skin had come into contact with something that I was allergic to because I didn't realize it was a drug reaction since that rash started on the 8th day antibiotics. |
|
| | Dispermox review by care giver of 4 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Ineffective |
| Side effects: | | Moderate Side Effects | | | Treatment Info |
| Condition / reason: | | ear infection |
| Dosage & duration: | | 4 mls 3x/day for 7 day (dosage frequency: 3) for the period of 7 day |
| Other conditions: | | took the medication few day after recovering from chicken pox |
| Other drugs taken: | | none | | | Reported Results |
| Benefits: | | To clear the ear infection she was having and the mild cough and other cold systom she was suffering from at the time. The drug is a penicilin-type antibiotic used to treat a wide variety of bacterial infections. |
| Side effects: | | Nausea vomiting or diarrhea may occur. the medicine may cause temporary staining of the teeth, serious side effects such as dark urine,persistent nausea or vomiting,stomach pain or cramping or blood or mucus in your stool. Prolong use oral thrush or a new viginal yeast infextion. White patch in your mouth a change in vaginal discharge or other new systoms. My child itch all over |
| Comments: | | I can't remember quite well but it was to take it after each meal 3 times a day. |
|
|
|
Page last updated: 2013-02-10
|